Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers - Wikidata - awgldk - TriplyDB

Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers

Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers

http://www.wikidata.org/entity/Q24620129

about

Human Microbiome Engineering: The Future and Beyond Advances in HIV microbicide development Microbicides: a new hope for HIV prevention Escherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection.Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors.Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease.Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus.Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide Vaginal microbiota and its role in HIV transmission and infection.Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy Enhanced neutralization of HIV by antibodies displayed on the S-layer of Caulobacter crescentus.Engineering commensal bacteria for prophylaxis against infection.Incorporation of the HIV-1 microbicide cyanovirin-N in a food product.Microbicides: still a long road to success Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide.Probiotic strategies for the treatment and prevention of bacterial vaginosis.Targeting CCR5 for anti-HIV research.Bioengineered probiotics as a new hope for health and diseases: an overview of potential and prospects.Diversity and stability of cultured vaginal lactobacilli in pregnant women from a multi-ethnic urban UK population.Development of Lactobacillus paracasei harboring nucleic acid-hydrolyzing 3D8 scFv as a preventive probiotic against murine norovirus infection.Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5 RANTES levels as a determinant of falciparum malaria severity or recovery.Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers.The Expanding Therapeutic Perspective of CCR5 Blockade.Vaginal Mucosa and Drug Delivery

P2860

Q26779114-3B3AE105-D36C-4E65-A79A-EE6723B200B0 Q26852858-C562E835-C98E-4CFA-8BD5-4E85AEE21C9B Q27022779-DE83D27D-1A05-4ED8-A65E-8B32A440B397 Q30153279-E5FC9958-6F72-4D04-BC48-F9DD16E18F03 Q30351993-DD36FFA6-A118-42DF-B8D4-4A40251CDA23 Q33733200-355EC1B7-DE27-462C-9D6D-3B9732606CDA Q34198191-50BFAEC7-FDE5-4C1E-9E29-DE0E68049F74 Q34539354-4FB04AD5-44D0-4CC4-878A-96C7212216B5 Q34780332-6B53A684-ED71-4BA1-8331-F611D3304DDB Q35019131-D6CC22B6-9DB6-4E01-A56E-468A99D128E9 Q35598601-6C8E839B-4768-4466-AFD5-0EA260D40C09 Q36074828-E8BBC46A-86CC-4D64-8AC6-E73F06F8EEFC Q36231045-C6061C06-D35E-44EF-8CB7-8A0CC7B73F8F Q37130757-D778C22C-7B09-4B1D-A759-7A1D60F27888 Q37255082-624E4732-32FD-4508-80E3-7EB4102D1B0E Q37544670-B21447D0-E85D-412A-92E8-9D57F13C0C19 Q37809873-40D2F15A-9FDD-4102-97CA-6E6F52349AD7 Q38229805-C921D3C2-674F-4444-BD15-24D2FC1BD721 Q38806283-D3A9CC0B-2FF7-4BAC-B71B-5EEE8234A18F Q40180521-F0E9317A-B948-4DC6-8DC0-1E26371E4216 Q41609991-106FF108-11E1-4A33-8A1D-0247FF0B0492 Q41897622-F6A2A819-2FEC-42A0-A103-7815A86F6161 Q44853870-D644A89C-C89F-4844-9A31-60DBA11E6824 Q47800411-F38FBA78-E5BB-4251-B450-89CDE4D4E828 Q47800556-37ADE664-AEC0-4DAE-9468-00DBE5B7E810 Q57570821-1E3FE41D-B99C-4AC0-964F-99A5C3DD4C14

P2860

Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers

http://www.wikidata.org/entity/Q24620129

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@ast

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@en

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@nl

type

label

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@ast

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@en

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@nl

prefLabel

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@ast

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@en

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@nl

P1433

Q24620129-7D0ED0CA-6958-4C14-ACCC-179BBA67C6FE

P1476

Q24620129-E9DCE2DA-936E-41BB-B7D9-92121CA48575

P2093

Q24620129-0AD25787-1C07-400C-9071-158B60AE8B24

Q24620129-1D01EAF3-149C-42BE-AAFA-72ED14FB6C57

Q24620129-8F1E0701-CDAA-4CE1-B950-C7F3667986BB

Q24620129-AB75756B-CAAA-47EE-88A7-35E0EC2151D2

Q24620129-B603B879-63F1-4755-B6C0-184033FA8F3C

Q24620129-BD8C7010-B800-432F-B490-487EA5D77001

Q24620129-EDC6FF16-76A7-4A30-90CB-F01DB06BED7A

P2860

Q24620129-0666E413-DDAB-41D7-BBF0-6EAAC310A32B

Q24620129-0D7B5B80-5003-4466-8D69-5DE482EC64D6

Q24620129-11449AD2-2192-409B-B98F-BC08A869F3C5

Q24620129-13360FF3-2DB0-4C04-97D9-CE86F3255E57

Q24620129-1DC8E0FB-C156-4580-8A6A-AC8A212F2BA6

Q24620129-22CCA6EB-DA69-4770-A27A-058F9380EC4C

Q24620129-2476027A-E3E3-4F83-B912-2214853A1926

Q24620129-273BD0AE-A370-4A12-AAA0-0F9077082E70

Q24620129-2F51C7C0-FE92-4F17-A2F6-E2721F9148E5

Q24620129-38C5337E-CDCD-4822-99C6-1FA8CAFBDF1D

P304

Q24620129-709D3D69-124D-4DE1-A1BD-0BC87C34D073

P31

Q24620129-B26EEACD-5E1A-46B1-9BEC-F5EC3F240EC3

P356

Q24620129-27261F65-1741-4487-8B00-5F09269A5FF3

P407

Q24620129-DCEE4AC7-F99C-4921-87D2-36C78FF9F060

P433

Q24620129-00349B11-F1A6-408A-B458-567F5393DAFB

P478

Q24620129-E1B53C15-FE5A-4559-BB03-526013417946

P577

Q24620129-372CE8FB-DFC0-4151-8AA4-ED401B4F19F9

P5875

Q24620129-D1CABE0D-C410-4F0D-996C-00A518015661

P698

Q24620129-0A3D961E-8AD3-4614-ADD9-B2BDBDCCA4CA

P921

Q24620129-E3F4EE54-B000-425C-B6EB-F49C0DCF5244

P932

Q24620129-7953A963-C728-4056-94AD-5E7CDA2CC172

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Engineering of Lactobacillus j ...... nalogue as live HIV-1 blockers

@en

P2093

Angela Bachi

http://www.w3.org/2001/XMLSchema#string

Letong Jia

http://www.w3.org/2001/XMLSchema#string

Luca Vangelista

http://www.w3.org/2001/XMLSchema#string

Massimiliano Secchi

http://www.w3.org/2001/XMLSchema#string

Paolo Lusso

http://www.w3.org/2001/XMLSchema#string

Qiang Xu

http://www.w3.org/2001/XMLSchema#string

Xiaowen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide.

HIV and the chemokine system: 10 years later.

Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES

The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N

The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants.

Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation.

P304

2994-3001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01492-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44608211

http://www.w3.org/2001/XMLSchema#string

P698

20479208

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

2897324

http://www.w3.org/2001/XMLSchema#string